|
| Home : Aphria Exercises Warrants for Gross Proceeds of $1.3 Million to Further Fund Tetra's Clinical Trials |
|
Mar 21
2017 |
Aphria Exercises Warrants for Gross Proceeds of $1.3 Million to Further Fund Tetra's Clinical Trials |
|
OTTAWA, ONTARIO--(Marketwired - March 20, 2017) - Tetra Bio-Pharma Inc. ("Tetra Bio" or "the Company") (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF) is pleased to announce that Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF) has exercised their 5,000,000 warrants for aggregate gross proceeds of $1,300,000. The proceeds from the warrant exercise will be used to advance the clinical trials being developed in PhytoPain Pharma Inc., a subsidiary of Tetra. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2203978&sourceType=3 |
| |
|
Related News
|
» Solarvest BioEnergy Inc. Extends $750,000 Second Tranche of Financing
» Millennial Esports Corp. Arranges Non-Brokered Private Placement
|
|
|
